# Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

> **NCT00433953** · PHASE1 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 44 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Mycophenolate Mofetil (CellCept)
- **BEHAVIORAL:** Dietary Monitoring
- **BEHAVIORAL:** Drug Diary
- **PROCEDURE:** Blood Sampling

## Key facts

- **NCT ID:** NCT00433953
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** No longer following patient and no plans to publish.
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433953, "Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00433953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*